2011-05-16T13:31:02-00:00 2010-06-30 990 2009-07-01 236296135 Institute for Cancer Research INST 2157282457 333 Cottman Avenue Philadelphia PA 191112497 Thomas S Albanesi Jr 2011-05-13 false 2009 2016-02-24 21:20:13Z Michael V Seiden MD PhD 333 Cottman Avenue Philadelphia PA 19111 28356653 false X www.fccc.edu X 1944 DE The Institute for Cancer Research is primarily engaged in basic research, including programs in Immune Cell Development and Host Defense, Cancer Biology, Developmental Therapeutics, Womens Cancer and Cancer Prevention and Control. 25 24 503 0 27289694 26510262 0 530549 369406 593956 703936 28414199 27583604 184816 312491 0 20823556 19028214 244947 0 231843 13748803 14369457 35002122 33710162 -6587923 -6126558 91072262 85640880 54785530 55585624 36286732 30055256 The Institute derives the majority of its research revenues through competitvely awarded research grants. Other research funding is derived from contributions, grants received from foundations and other private organizations or individuals, licensure of Institute technology, and income from investments. The Institute engages in scientific research for the benefit of Fox Chase Cancer Center research activities to prevail over cancer. true false 22185600 27583604 The division of Basic Science is renowned world-wide for its work in understanding both normal and abnormal cell growth. Scientists are involved in studies of genes that cause or inhibit cancer growth, virology, immunology, chemical carcinogens, cell growth and interaction and gene expression. In recent years, research has increasingly emphasized molecular oncology and genetics, areas which bridge advancing knowledge from the laboratory with new clinical approaches. 6939956 The research facilities have been structured to fulfill the needs of the multi-disciplinary research programs at Fox Chase Cancer Center. The facilities have been designed to enhance on-going research by supplying information, reagents, and technical expertise that are not readily available to the individual investigator. 29125556 true true false true false false false false true true false true false false false false false false false false false false true true false false false false false false false true false false false false false true false false false true 0 0 503 true false false false false false false false false false false false false false false 25 24 false false false false false false false true true false true true true true true true true true true true false PA NJ X Thomas S Albanesi Jr Chief Financia 2157282457 333 Cottman Avenue Philadelphia PA 19111 X Michael V Seiden MD PhD 040.00 X 0 530790 15973 Paul F Engstrom MD 040.00 X 0 431552 17465 Jeff Boyd PhD 040.00 X 0 421592 21796 J Robert Beck MD 040.00 X 0 364444 8849 Joseph F Hediger 040.00 X 0 311527 17095 Gary J Weyhmuller 040.00 X 0 311538 21545 Susan H Tofani 040.00 X 0 311496 5127 Robert G Wilkens 040.00 X 0 69231 175 Mary B Daly MD PhD 040.00 X 0 345309 10391 Anna Marie Skalka PhD 040.00 X 0 305785 17474 Jill L Marsteller 040.00 X 0 234548 13842 Robert C Young 040.00 X 0 206344 12472 R Donald Leedy 040.00 X 0 176102 0 Christine Wilson 040.00 X 0 146872 0 John B Burch 040.00 X 239007 0 10596 Harry Rozmiarek 040.00 X 191245 0 1529 John M Taylor 040.00 X 187121 0 8311 William S Mason 040.00 X 173428 0 15538 Richard R Hardy 040.00 X 169832 0 19005 Jonathan Chernoff 040.00 X 281575 0 8621 Erica A Golemis 040.00 X 159318 0 19272 David G Marshall 005.00 X 0 0 0 W Thacher Brown 005.00 X 0 0 0 Louis E Della Penna Sr 005.00 X 0 0 0 Thomas W Hofmann 005.00 X 0 0 0 Margot W Keith 005.00 X 0 0 0 Peter McCausland 005.00 X 0 0 0 William J Avery 005.00 X 0 0 0 G Morris Dorrance Jr 005.00 X 0 0 0 The Honorable Dwight Evans 005.00 X 0 0 0 Edward A Glickman 005.00 X 0 0 0 Michael J Heller Esq 005.00 X 0 0 0 Lawrence T Hoyle Jr Esq 005.00 X 0 0 0 Philip E Lippincott 005.00 X 0 0 0 William G Little 005.00 X 0 0 0 Jill Michal 005.00 X 0 0 0 Donald E Morel Jr PhD 005.00 X 0 0 0 Jane G Pepper 005.00 X 0 0 0 Edward J Roach 005.00 X 0 0 0 Thomas Shenk PhD 005.00 X 0 0 0 Pamela Strisofsky 005.00 X 0 0 0 William Stulginsky 005.00 X 0 0 0 Thomas R Tritton PhD 005.00 X 0 0 0 Kenneth E Weg 005.00 X 0 0 0 Yoram Jerry Wind PhD 005.00 X 0 0 0 Zane Wolf PhD 005.00 X 0 0 0 Debra Sniger Ex Officio 005.00 X 0 0 0 Michael V Seiden MD PhD Ex Officio 005.00 X 0 0 0 1401526 4167130 245076 34 true true false P Agnes Inc 2101 Penrose Avenue Philadelphia PA 19145 Professional Services 3126990 M R Rose Construction Ince 463 Kenwood Road Huntingdon Valley PA 19006 Professional Services 431373 Nutrition Management Solutions PO Box 725 Kimberton PA 19442 Professional Services 425417 Pennsylvania State University 500 University Drive PO Box 850 Hershey PA 17033 Professional Services 375879 Ewing Cole 100 North 6th Street Philadelphia PA 19106 Professional Services 362345 5 23012741 3497521 26510262 585433 585433 568685 568685 468818 333567 135251 135251 223455 439482 -216027 -216027 27583604 1154118 0 312491 312491 0 0 1401526 1401526 0 12904160 11607837 1296323 153312 139248 14064 3602829 3537346 65483 966387 877737 88650 0 361542 19971 341571 75841 75841 0 0 -727303 -176613 -550690 7842 7842 506721 55691 451030 617318 324306 293012 0 5082106 3955337 1126769 359860 336509 23351 0 210208 189401 20807 694190 535863 158327 0 4848922 4142264 706658 132339 79195 53144 Purchase Services 2199871 1779605 188423 231843 0 33710162 29125556 4352763 231843 193301 3116614 2557621 4432484 2492708 -6012130 1054707 816375 130687850 70848737 63253076 61936419 3552556 3161294 16870295 16967984 1097998 1221840 91072262 85640880 9032800 8596353 1567462 1571274 33153315 32635066 11031953 12782931 54785530 55585624 X 22244049 14755714 113625 374094 13929058 14925448 36286732 30055256 91072262 85640880 X false true true X true true X American Oncologic Hospital Philadelphia PA 0.00000 0.00000 0.00000 Part II Line 10 N/A Part II Line 17a N/A Part II Line 17b N/A Part III Line 12 N/A RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 5969 50284 5969 50284 33472350 347256258 33478319 347306542 1000000 1000000 250000 250001 1000000 1000000 1000000 1000000 4000000 6000000 54667 57747 157246 50284 319944 250000 250000 250000 250001 1000001 1500002 false false false false false false false false false false false I-A 1 Management has had discussions with Congressional represtatives to provide input on Health Care Reform matters. Such dicussions included the role of Comprehensive Cancer Centers, payment issues affecting Cancer Hospitals, issues affecting beneficiary access to comprehensive cancer centers including the importance of maintaining coverage for clinical trials, importance of maintaining and strengthening funding levels for cancer research and recommendations to broaden prevention and screeing I-A 1 benefits under the Medicare program. Additionally, to assist the organization obtain needed funding for cutting edge technologies and resources utilized by the scientific and clinical faculty, the Center annually seeks federal support through various legislative appropriation mechanisms. This typically involves submission of a grant/proposals and may require ongoing dialogue and/or meetings with Congressional members and their staffs to discuss the merits of the proposals. I-A 1 Management also meets with and corresponds with members of the State House and Senate regarding the importance of ongoing funding to organizations that are involved in cancer research and how this funding contributes significantly to more favorable outcomes in the fight against cancer and with economic development. I-B 4b Not Applicable I-C 5 Not Applicable false 3552556 1000 309714 76976 625000 3161294 8093846 279853 -1518099 16591 3286453 3552556 0.01000 0.12000 0.87000 true true true 61164 61164 76639790 55627657 42315323 2379170 518326 1856249 26125744 14415784 12510554 25481982 286970 5193129 61936419 Other Investments 4813206 F Funds Held in Trust 12154778 F 16967984 Issuance Costs 1221840 1221840 FAS 112 Costs 342000 Mark-to-Market Liability 7191536 Long Term Workers Compensation 3122611 FAS 106 Costs 1303381 Security Deposit 4000 FAS 143 Costs 641613 Capital Lease Obligations 177790 12782931 27583604 33710162 -6126558 183945 -1071530 782667 -104918 -6231476 27583604 27583604 27583604 33710162 33710162 33710162 II 3 N/A II 5 N/A II 9 N/A III 1a N/A III 4 N/A IV 1b N/A IV 2b N/A V 4 Appointment to an endowed chair rewards a scientists professional contributions, recognizes the value of his/her research endeavors and safeguards the funding needed to continue these pioneering inquiries. Those who support a chair endowment become vital partners in our scientist groundbreaking, lifesaving discoveries. Endowing and naming a chair provides the opportunity to honor a loved one with a memorial that will last for many, many years. Endowed chairs provide a steady and V 4 predicatable flow of funds in perpetuity, allowing the institutions to strengthen the quality of its programs and services beyond levels that other funding sources alone could support. Board designated funds give the Institute for Cancer Researchs researches the flexible funding to initiate new research programs for the prevention, detection, and treatment of cancer. The funds assist patients and their families receive the best support and provide important services to the community. X N/A X X X X X X X false NJ PA true William J Avery Endowed Postdoctoral Fellowship 2 44746 FMV N/A Reimann Fellowship 1 6355 FMV N/A Board of Associates Plain Fancy Fellowship 2 35409 FMV N/A Lawrence Greenwald Postdoctoral Fellowship 2 68983 FMV N/A ICR Postdoctoral Fellowship 1 23352 FMV N/A Ewing Fellowship 1 20570 FMV N/A Elizabeth Knight Patterson Fellowship 1 32857 FMV N/A Greenberg Fellowship 2 42965 FMV N/A F. M. Kirby Postdoctoral Fellowship 1 37254 FMV N/A I 2 The appointment for postdoctoral training can begin upon completion of all requirements for the doctoral degree. Those appointed under the training grants I 2 from NCI may have no more than three years of postdoctoral experience and must be a U.S. citizen or permanent residence visa. The programs emphasize mentored I 2 research supervision, multidisciplinary seminars, clinical rounds, workshops in research technology and in scientific writing, grant and manuscript critical review. X X X X X true false false false false false false false false Michael V Seiden MD PhD 492692 38098 15973 546763 Paul F Engstrom MD 429752 1800 2297 15168 449017 Jeff Boyd PhD 363462 58130 2692 19104 443388 J Robert Beck MD 352848 11596 2615 6234 373293 Joseph F Hediger 311527 2308 14787 328622 Gary J Weyhmuller 311538 2308 19237 333083 Susan H Tofani 311496 2308 2819 316623 Mary B Daly MD PhD 329732 15577 2492 7899 355700 Anna Marie Skalka PhD 305785 3404 14070 323259 Jill L Marsteller 230358 4190 2308 11534 248390 Robert C Young 181029 25000 315 2550 9922 218816 R Donald Leedy 173385 2717 176102 Christine Wilson 141795 5077 146872 John B Burch 79297 14519 145191 1117 9479 249603 Harry Rozmiarek 191245 918 611 192774 John M Taylor 187121 1386 6925 195432 William S Mason 173428 1285 14253 188966 Richard R Hardy 162043 7789 1258 17747 188837 Jonathan Chernoff 218077 51923 11575 2000 6621 290196 Erica A Golemis 151529 7789 1180 18092 178590 I 1a N/A I 1b N/A I 4c N/A I 5a N/A I 5b N/A I 6a N/A I 6b N/A I 7 N/A I 8 N/A II N/A Peter McCausland - Airgas Board of Director 71430 Acquisition of Specialty gases false Form 990 III 2 In May 2009, Fox Chase launched the Institute for Personalized Medicine, a program aimed at matching emerging targeted drug therapies to the unique genetic profiles of individual patient tumors. Its first ambitious projects focus on understanding the biology of rate types of sarcoma and ovarian cancer. The Institute builds on Fox Chases already substantial annotated Biosample Repository and Tumor Bank to add new layers of knowledge about the genetic information in individual patient tumors. Form 990 III 3 N/A Form 990 III 4d N/A Form 990 V 3a N/A Form 990 VI 2-7b N/A Form 990 VI 8 N/A Form 990 VI 9b N/A Form 990 VI 11a The Form 990 is prepared internally by management and reviewed by several members of the Finance Department including both the Vice President - Finance and the Sr. Vice President - Finance CFO, members of the Senior Leadership Committee and the Audit Committee of the Board of Directors. They are also reviewed by the tax department of the organizations independent auditors. Form 990 VI 12c In the case of potential conflict of interest or commitment, the President of FCCC shall be responsible for administering all matters. All disclosures shall be kept confidential, in a separate file under the control of the Office of the President. They shall not be made part of any personnel record or the basis for any review of the performance of the individual staff member. Access to these records shall be made available only to Board members, the President or his designee or a properly authorized govenmental body, acting under statutory or regulatory authority. Records will be maintained for three years unless the materials are subject to governmental action. Disclosures shall be required of all staff and board members as follows By Board Members- All Board Members of FCCC shall be required to complete a Conflict of Interest Disclosure form at the time of appointment, annually Form 990 VI 12c and whenever a new potential conflict arises. By Employees All scientist, Physicians and administrative employees at the management level and above of FCCC shall be required to complete a Conflict of Interest form at the time of employment, annually and whenever a new potential conflict arises and submit such disclosure forms to the Chief Academic Officer or his designee. By Consultants and Subcontractors Consultants and Subcontractors shall certify to FCCC that they are not in a position to influence Center business, research or other decisions in ways that could lead to any form of personal gain from them or their family or give improper advantage to others to the Centers detriment. Form 990 VI 15b The organizations compensation policy for the positions of CEO, Executive Directors, senior management, officers and/or key employees is to utilize a national survey facility for compensation information. It is reviewed by the organization compensation committee as well as the Board for approval. Form 990 VI 19 The organizations governing documents, conflict of interest policy, and financial statements are made available to the public when requested. Fox Chase Cancer Center 333 Cottman Avenue Philadelphia PA 19111 232003072 Research DE 4 501c3 Not Applicable American Oncologic Hospital 333 Cottman Avenue Philadelphia PA 19111 231352156 Patient Care PA 3 501c3 Not Applicable Health Services of Fox Chase Cancer Center 333 Cottman Avenue Philadelphia PA 19111 232328543 Patient Care PA 3 501c3 Not Applicable Fox Chase Network 333 Cottman Avenue Philadelphia PA 19111 232467337 Clinical Services PA 11b 501c3 Not Applicable Fox Chase Select 76 ST Paul Street Burlington VT 05401 020597423 Captive Insurance VT 11a 501c3 Not Applicable Fox Chase Limited 333 Cottman Avenue Philadelphia PA 19111 232396731 Medical Services PA Not Applicable C Corp false false false false false false false false false false false false true true true true false false Institute for Cancer Research 333 Cottman Avenue Philadelphia PA 191112497 236296135 X 0 5969 5969 33472350 33478319 96394 24099 0 0 0 Fox Chase Cancer Center 333 Cottman Avenue Philadelphia PA 191112497 232003072 0 10600 10600 53894495 53905095 155209 38802 0 0 0 American Oncologic Hospital 333 Cottman Avenue Philadelphia PA 191112497 231352156 0 30452 30452 203997598 204028050 587458 146865 0 0 0 Health Services of FCCC 333 Cottman Avenue Philadelphia PA 191112497 232328543 0 3263 3263 53894495 53897758 155188 38797 0 0 0 Fox Chase Network 333 Cottman Avenue Philadelphia PA 191112497 232467337 0 0 0 1997320 1997320 5751 1438 0 0 0